CG Oncology Inc. (CGON) vs Sotera Health Company (SHC)

A side-by-side comparison of CG Oncology Inc. and Sotera Health Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGON vs SHC

growth of $100 · dividends reinvested · last 3y
CGON +84.9% (+22.7%/yr)SHC +26.8% (+8.2%/yr)CGON compounded faster over this window
50100150200Start $10020252026$185$127
CGON SHC

CGON vs SHC: by the numbers

  • •CGON is the larger company ($5.65B vs $5.24B market cap).
  • •SHC is profitable (13.44% net margin) while CGON runs a net loss (-3602.68%).

Metrics side by side

Valuation

MetricCGONSHC
P/E ratioN/A32.11
Forward P/EN/A18.67
P/S ratio906.774.31
P/B ratio5.497.87
EV / EBITDAN/A12.49
FCF yieldN/A2.15%

Profitability

MetricCGONSHC
Gross margin-15.02%54.72%
Operating margin-4722.13%36.24%
Net margin-3602.68%13.44%
ROE-21.80%24.56%
ROIC-24.33%8.80%

Growth (annualized)

MetricCGONSHC
Revenue CAGR (5Y)N/A6.66%
FCF CAGR (5Y)N/A17.34%
Total return CAGR (5Y)N/A-6.39%

Frequently asked

Is CGON or SHC more profitable?
SHC runs the higher net margin — CGON at -3602.68% versus SHC at 13.44%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.